Sherry Wu

Dr Sherry Wu is a Senior Lecturer at the University of Queensland, Faculty of Health, Medicine and Behavioural Sciences, within the School of Biomedical Sciences. She leads the Cancer Therapeutics Lab and is affiliated with the Centre for Extracellular Vesicle Nanomedicine. Her research focuses on developing novel cancer therapies, particularly for ovarian and breast cancers, using nanotechnology, RNA therapeutics, and immune modulation.

Education:

• Bachelor of Pharmacy (Honours), The University of Queensland
• Doctor of Philosophy (PhD), The University of Queensland
• Graduate Certificate in Translational Cancer Research, University of Texas M.D. Anderson Cancer Center (TRIUMPH program)

Research Interests: Dr Wu’s research spans cancer therapeutics, nanomedicine, RNA interference, extracellular vesicles, and immune-oncology. Her lab is dedicated to understanding and overcoming immune suppression in ovarian and breast cancers, developing nanoparticle-based drug delivery systems, and engineering exosomes for therapeutic purposes.

Publications & Trends: She has authored over 65 peer-reviewed publications, including high-impact journals such as Nature Communications, Biomaterials, Cancer Immunology, Immunotherapy, and Molecular Therapy. Her work consistently explores innovative delivery systems, miRNA-based therapies, and immune modulation strategies in cancer.

Awards & Grants:

• Cancer Institute NSW Career Development Fellowship
• NHMRC IDEAS Grants (2023–2026, 2025–2029)
• Ovarian Cancer Research Foundation Grants
• Liz Tilberis Early Career Award (2016–2019)
• NIH R35 Maximizing Investigators’ Research Award

Supervision & Mentorship: Dr Wu is actively supervising PhD students in areas such as immune suppression in cancer, nanosystem development, and exosome targeting strategies. She has successfully graduated students and continues to mentor early-career researchers.

Labs & Teams: She heads the Cancer Therapeutics Lab at UQ and collaborates with national and international research teams, including the Centre for Extracellular Vesicle Nanomedicine and the Faculty of Health, Medicine and Behavioural Sciences.